Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

New England Journal of Medicine - Tập 361 Số 24 - Trang 2342-2352 - 2009
Sam Schulman1,2, Clive Kearon2, Ajay K. Kakkar3, Aurélien Delluc4, Sebastian Schellong5, David Baanstra6, Janet Schnee7, Samuel Z. Goldhaber8
1Department of Hematology, Karolinska University Hospital, Stockholm
2Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, ON, Canada
3Thrombosis Research Institute and Queen Mary University of London, London
4Department of Vascular Pathology, Bellevue Hospital, Saint Etienne, France
5Medical Division 2, Municipal Hospital Friedrichstadt, Dresden, Germany
6Clinical Research, Boehringer Ingelheim, Alkmaar, the Netherlands
7Boehringer Ingelheim, Ridgefield, CT
8Brigham and Women’s Hospital, Harvard Medical School, Boston

Tóm tắt

Từ khóa


Tài liệu tham khảo

Oger E, 2000, Thromb Haemost, 83, 657, 10.1055/s-0037-1613887

10.1111/j.1525-1497.2006.00458.x

10.1378/chest.08-0658

10.1378/chest.08-0670

10.1592/phco.28.11.1354

10.1111/j.1538-7836.2007.02748.x

10.1016/S0140-6736(07)61445-7

10.1056/NEJMoa0905561

10.1111/j.1538-7836.2005.01204.x

10.1111/j.0954-6820.1985.tb06125.x

Levine MN, 1995, Thromb Haemost, 74, 606, 10.1055/s-0038-1649783

10.1111/j.0954-6820.1985.tb03261.x

10.1056/NEJM199506223322501

10.1038/clpt.2009.98

10.1111/j.1538-7836.2008.03075.x

Gould MK, 1999, Ann Intern Med, 130, 789, 10.7326/0003-4819-130-10-199905180-00002

10.1001/archinte.151.10.1944

10.1001/jama.293.6.681

10.1056/NEJMoa030104

10.1016/j.amjcard.2007.06.034

10.1016/S0140-6736(86)91431-5

10.1056/NEJM199005033221802